These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

6274 related items for PubMed ID: 20197344

  • 1. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
    Kanzaki R, Higashiyama M, Maeda J, Okami J, Hosoki T, Hasegawa Y, Takami M, Kodama K.
    Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344
    [Abstract] [Full Text] [Related]

  • 2. 18F-fluorodeoxyglucose positron emission tomography/computed tomography is useful in postoperative follow-up of asymptomatic non-small-cell lung cancer patients.
    Toba H, Sakiyama S, Otsuka H, Kawakami Y, Takizawa H, Kenzaki K, Kondo K, Tangoku A.
    Interact Cardiovasc Thorac Surg; 2012 Nov; 15(5):859-64. PubMed ID: 22914804
    [Abstract] [Full Text] [Related]

  • 3. [Impact of positron emission tomography on clinical management of potentially resectable non-small-cell lung cancer: a French prospective multicenter study].
    Margery J, Milleron B, Vaylet F, Grahek D, Lebeau B, Mangiapan G, Bonardel G, de Labriolle-Vaylet C, Meignan M, Carette MF, Talbot JN, Housset B.
    Rev Pneumol Clin; 2010 Oct; 66(5):313-20. PubMed ID: 21087727
    [Abstract] [Full Text] [Related]

  • 4. Lymph node metastasis diagnosis using positron emission tomography with 2-[18F] fluoro-2-deoxy-D-glucose as a tracer and computed tomography in surgical cases of non-small cell lung cancer.
    Ose N, Sawabata N, Minami M, Inoue M, Shintani Y, Kadota Y, Okumura M.
    Eur J Cardiothorac Surg; 2012 Jul; 42(1):89-92. PubMed ID: 22290887
    [Abstract] [Full Text] [Related]

  • 5. Impact of 18F-FDG PET/CT in the treatment of patients with non-small cell lung cancer.
    Taus Á, Aguiló R, Curull V, Suárez-Piñera M, Rodríguez-Fuster A, Rodríguez de Dios N, Pijuan L, Zuccarino F, Vollmer I, Sánchez-Font A, Belda-Sanchis J, Arriola E.
    Arch Bronconeumol; 2014 Mar; 50(3):99-104. PubMed ID: 24360985
    [Abstract] [Full Text] [Related]

  • 6. Diagnosis of recurrence and follow-up using FDG-PET/CT for postoperative non-small-cell lung cancer patients.
    Toba H, Kawakita N, Takashima M, Matsumoto D, Takizawa H, Otsuka H, Tangoku A.
    Gen Thorac Cardiovasc Surg; 2021 Feb; 69(2):311-317. PubMed ID: 32909168
    [Abstract] [Full Text] [Related]

  • 7. Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging.
    Shim SS, Lee KS, Kim BT, Chung MJ, Lee EJ, Han J, Choi JY, Kwon OJ, Shim YM, Kim S.
    Radiology; 2005 Sep; 236(3):1011-9. PubMed ID: 16014441
    [Abstract] [Full Text] [Related]

  • 8. PET/CT using 18F-FDG in suspected lung cancer recurrence: diagnostic value and impact on patient management.
    Keidar Z, Haim N, Guralnik L, Wollner M, Bar-Shalom R, Ben-Nun A, Israel O.
    J Nucl Med; 2004 Oct; 45(10):1640-6. PubMed ID: 15471827
    [Abstract] [Full Text] [Related]

  • 9. Positron emission tomography-computed tomography compared with invasive mediastinal staging in non-small cell lung cancer: results of mediastinal staging in the early lung positron emission tomography trial.
    Darling GE, Maziak DE, Inculet RI, Gulenchyn KY, Driedger AA, Ung YC, Gu CS, Kuruvilla MS, Cline KJ, Julian JA, Evans WK, Levine MN.
    J Thorac Oncol; 2011 Aug; 6(8):1367-72. PubMed ID: 21587082
    [Abstract] [Full Text] [Related]

  • 10. Performance of (18)F-FDG PET/CT as a postoperative surveillance imaging modality for asymptomatic advanced gastric cancer patients.
    Lee DY, Lee CH, Seo MJ, Lee SH, Ryu JS, Lee JJ.
    Ann Nucl Med; 2014 Oct; 28(8):789-95. PubMed ID: 24965850
    [Abstract] [Full Text] [Related]

  • 11. Mediastinal lymph nodes staging by 18F-FDG PET/CT for early stage non-small cell lung cancer: a multicenter study.
    Li X, Zhang H, Xing L, Ma H, Xie P, Zhang L, Xu X, Yue J, Sun X, Hu X, Chen M, Xu W, Chen L, Yu J.
    Radiother Oncol; 2012 Feb; 102(2):246-50. PubMed ID: 22100657
    [Abstract] [Full Text] [Related]

  • 12. Combined [18F]Fluorodeoxyglucose positron emission tomography and computed tomography (FDG-PET/CT) for detection of recurrent, 131I-negative thyroid cancer.
    Finkelstein SE, Grigsby PW, Siegel BA, Dehdashti F, Moley JF, Hall BL.
    Ann Surg Oncol; 2008 Jan; 15(1):286-92. PubMed ID: 17882493
    [Abstract] [Full Text] [Related]

  • 13. False-negative rate after positron emission tomography/computer tomography scan for mediastinal staging in cI stage non-small-cell lung cancer.
    Gómez-Caro A, Boada M, Cabañas M, Sanchez M, Arguis P, Lomeña F, Ramirez J, Molins L.
    Eur J Cardiothorac Surg; 2012 Jul; 42(1):93-100; discussion 100. PubMed ID: 22290911
    [Abstract] [Full Text] [Related]

  • 14. Clinical utility of F-18 FDG PET/CT in recurrent breast carcinoma.
    Manohar K, Mittal BR, Senthil R, Kashyap R, Bhattacharya A, Singh G.
    Nucl Med Commun; 2012 Jun; 33(6):591-6. PubMed ID: 22334135
    [Abstract] [Full Text] [Related]

  • 15. Is mediastinoscopy still the gold standard to evaluate mediastinal lymph nodes in patients with non-small cell lung carcinoma?
    Sivrikoz CM, Ak I, Simsek FS, Döner E, Dündar E.
    Thorac Cardiovasc Surg; 2012 Mar; 60(2):116-21. PubMed ID: 21692019
    [Abstract] [Full Text] [Related]

  • 16. Stage T1 non-small cell lung cancer: preoperative mediastinal nodal staging with integrated FDG PET/CT--a prospective study.
    Kim BT, Lee KS, Shim SS, Choi JY, Kwon OJ, Kim H, Shim YM, Kim J, Kim S.
    Radiology; 2006 Nov; 241(2):501-9. PubMed ID: 16966480
    [Abstract] [Full Text] [Related]

  • 17. Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography.
    Billé A, Pelosi E, Skanjeti A, Arena V, Errico L, Borasio P, Mancini M, Ardissone F.
    Eur J Cardiothorac Surg; 2009 Sep; 36(3):440-5. PubMed ID: 19464906
    [Abstract] [Full Text] [Related]

  • 18. F18-FDG-PET/CT in the evaluation of patients with suspected recurrent or persistent locally advanced cervical carcinoma.
    Cetina L, Serrano A, Cantú-de-León D, Pérez-Montiel D, Estrada E, Coronel J, Hernández-Lucio M, Dueñas-González A.
    Rev Invest Clin; 2011 Sep; 63(3):227-35. PubMed ID: 21888286
    [Abstract] [Full Text] [Related]

  • 19. Diagnostic accuracy of virtual 18F-FDG PET/CT bronchoscopy for the detection of lymph node metastases in non-small cell lung cancer patients.
    Herbrik M, Treffert J, Geiger B, Riegger C, Hartung V, Rosenbaum-Krumme SJ, Forsting M, Antoch G, Heusner TA.
    J Nucl Med; 2011 Oct; 52(10):1520-5. PubMed ID: 21908390
    [Abstract] [Full Text] [Related]

  • 20. [The application of 18F-fluorodeoxyglucose positron emission tomography in the diagnosis and staging of lung cancer].
    Xu HF, Liu Y, Zhang JH, Zhou RS, Zhou FH, Yuan MH.
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Feb; 28(2):108-11. PubMed ID: 15854393
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 314.